The $156 Multi Lilly Hearts Disney Ballad Sweatshirt is becoming a vacation must-have despite being slightly smaller than the ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Complete Invesco MSCI World Universal Screened UCITS ETF funds overview by Barron's. View the ESGG funds market news ...

Lilly beats Novo Nordisk to launch weight-loss drug in India Mounjaro's 5 mg vial priced at around $50, 2.5 mg at about $40 Drug's pricing may limit accessibility in India, analyst says Novo's ...

Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our P/B Growth Investor model based on the published strategy of ...

Eli Lilly (LLY) closed the latest trading day at $822.51, indicating a -0.27% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 1.07%.

Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our P/B Growth Investor model based on the published strategy of ...

Despite a massive 24.4% R&D-to-Revenue ratio in FY2024, LLY's operating margin expanded by more than seven percentage points compared to FY2023. The company's TTM R&D spending is massive at almost ...

Hims & Hers app downloads surged 47% in February. Demand for GLP-1 weight-loss drugs is the most likely reason for the growth. But sales of such weight loss drugs are going away soon, and the ...

Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Novo Nordisk (NVO) and Eli Lilly (LLY). But which of these two stocks is more attractive to ...

NYSE LLY opened at $813.55 on Monday. Eli Lilly and Company has a 1-year low of $711.40 and a 1-year high of $972.53. The company has a market capitalization of $771.38 billion, a P/E ratio of 69. ...